Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

Model and clinical segmentation examples. (A) 71-year-old female with non-small cell lung cancer (NSCLC) from the internal test set. (B) 87-year-old male with NSCLC from the external test set. Both ...

Results of an artificial intelligence–based tool to predict financial toxicity early to facilitate early referral to hospital social workers. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...

OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

Early findings from the FANSS study, presented at ESMO Asia 2025, point to a potential shift in how clinicians identify lung ...

SEVEN NEWS. LUNG CANCER REMAINS THE LEADING CAUSE OF CANCER RELATED DEATH IN THE UNITED STATES. AS MEDICAL EXPERT DOCTOR RAMO EXPLAINS, RECENT GUIDELINE CHANGES COULD HELP SAVE THOUSANDS OF LIVES.